Safety, Efficacy, Pharmacokinetic (PK) and Biomarker Analyses of BCL2 Inhibitor Venetoclax (Ven) Plus MDM2 Inhibitor Idasanutlin (idasa) in Patients (pts) with Relapsed or Refractory (R/R) AML: A Phase Ib, Non-Randomized, Open-Label Study

Naval Daver ,Patrick Phuong,Pierre Fenaux,Giuseppe Visani,Gail J Roboz,Jacqueline S Garcia,Monique Dail,Connie Ma,Jue Wang,Michael Andreeff,Sarit Assouline,Norbert Vey,Agostino Tafuri,Brian A Jonas,Cherie Green,Mehrdad Mobasher,Daniel A Pollyea ,Rebecca L Olin ,Whitney P Kirschbrown ,Wan‐Jen Hong ,Marion Ott ,Karen Yee ,Marina Konopleva

doi:10.1182/blood-2018-99-116013

Safety, Efficacy, Pharmacokinetic (PK) and Biomarker Analyses of BCL2 Inhibitor Venetoclax (Ven) Plus MDM2 Inhibitor Idasanutlin (idasa) in Patients (pts) with Relapsed or Refractory (R/R) AML: A Phase Ib, Non-Randomized, Open-Label Study

Naval Daver , Patrick Phuong + Show 21 more

Open Access

https://doi.org/10.1182/blood-2018-99-116013

Copy DOI

Journal: Blood	Publication Date: Nov 29, 2018
Citations: 23

Affiliation: The University of Texas MD Anderson Cancer Center, Délégation Paris 7, Hôpital Saint-Louis, Université Paris Cité, San Salvatore Hospital, Cornell University, Dana-Farber Cancer Institute, Jewish General Hospital, Institute Paoli-Calmettes, University of California, Davis, University of Colorado Denver, University of California, San Francisco, Roche (Switzerland), Princess Margaret Cancer Centre, University Health Network

#Research Funding #Advisory Committees + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Safety, Efficacy, Pharmacokinetic (PK) and Biomarker Analyses of BCL2 Inhibitor Venetoclax (Ven) Plus MDM2 Inhibitor Idasanutlin (idasa) in Patients (pts) with Relapsed or Refractory (R/R) AML: A Phase Ib, Non-Randomized, Open-Label Study

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.